Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis

Jaiswal, Sanjay; Liu, Xianbao; Wei, Qucheng; Sun, Ying-hao; Wang, Lihan; Song, Liuguang; Yang, Dandan; Wang, Jianan

doi:10.1631/jzus.b1600529

Cited by 6 publications

(4 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, inflammation plays a role in AF. A meta-analysis suggested that periprocedural administration of corticosteroids after catheter ablation was associated with a reduction in early but not late recurrence of AF [27].…”

Section: Preprocedural Screeningmentioning

confidence: 99%

Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview

Marini

Pannone

Rocca

et al. 2022

JCDD

View full text Add to dashboard Cite

Electrical isolation of pulmonary veins (PVI) is the cornerstone of invasive treatment of atrial fibrillation (AF). However, arrhythmia-free survival of a PVI only approach is suboptimal in patients with persistent and long-term persistent AF. Hybrid AF ablation has been developed with the aim of combining the advantages of a thoracoscopic surgical ablation (direct visualization of anatomical structures to be spared and the possibility to perform epicardial lesions) and endocardial ablation (possibility to check line block, confirm PVI, and possibility to perform cavotricuspid isthmus ablation). Patient selection is of utmost importance. In persistent and long-term persistent AF, hybrid AF ablation demonstrated promising results in terms of AF free survival. It has been associated with a relatively low complication rate if performed in centers with expertise in hybrid procedures and experience with both surgical and endocardial ablation. Different techniques have been described, with different approaches and lesion sets. The aim of this review is to provide a state-of-the-art overview of hybrid AF ablation.

show abstract

Section: Preprocedural Screeningmentioning

confidence: 99%

Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview

Marini

Pannone

Rocca

et al. 2022

JCDD

View full text Add to dashboard Cite

show abstract

“…Historically, molecules employed to reduce ER include AADs, corticosteroids, and colchicine. Still, only the latter has shown favorable long‐term outcomes 4,50–53 . The idea of early redo ablation is not a novel one.…”

Section: Discussionmentioning

confidence: 99%

“…Still, only the latter has shown favorable long-term outcomes. 4,[50][51][52][53] The idea of early redo ablation is not a novel one. In 2008, Lellouche et al 54 reported that early reablation (for arrhythmia recurrence during the first month of the BP) was associated with increased arrhythmia-free survival in the long-term (51% vs. 91% p, < .0001).…”

Section: Discussionmentioning

confidence: 99%

Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta‐analysis

Vrachatis

Papathanasiou

Kossyvakis

et al. 2022

Cardiovasc electrophysiol

View full text Add to dashboard Cite

Introduction: Early arrhythmia recurrence within the 3-month blanking period is a common event that historically has been attributed to reversible phenomena. While its mechanistic links remain obscure, accumulating evidence support the argument of shortening the blanking period. We aimed to elucidate the association between early and late arrhythmia recurrence after atrial fibrillation cryoablation. Methods:The MEDLINE database, ClinicalTrials. gov, medRxiv, and Cochrane Library were searched for studies evaluating early and late arrhythmia recurrence rates in patients undergoing cryoablation for atrial fibrillation. Data were pooled by meta-analysis using a random-effects model. The primary endpoint was late arrhythmia recurrence.Results: Early arrhythmia recurrence was found predictive of decreased arrhythmiafree survival after evaluating 3975 patients with paroxysmal or persistent atrial fibrillation who underwent cryoablation (odds ratio [OR]: 5.31; 95% confidence interval [

show abstract

“…The following information was extracted from each study: first author, title, journal name, publication date, study periods, regions, sample size, demographic data (e.g., gender, age), chronic medical conditions (e.g., comorbidities, smoking history), clinical features (e.g., fever, headache), laboratory results (e.g., leukocytes, neutrophils), and radiographical features (e.g., ground-glass opacity, bilateral pulmonary infiltration). Three components, including selection, comparability, and exposure or outcome, were assessed for each study using the Newcastle-Ottawa Scale (Jaiswal et al, 2018;Xu and Lu, 2019). This consisted of eight items with a full score of nine stars (Stang, 2010).…”

Section: Data Extraction and Quality Assessmentmentioning

confidence: 99%

Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis

Yao

Zheng

et al. 2020

J. Zhejiang Univ. Sci. B

View full text Add to dashboard Cite

Background: The proportion of recurrences after discharge among patients with coronavirus disease 2019 (COVID-19) was reported to be between 9.1% and 31.0%. Little is known about this issue, however, so we performed a meta-analysis to summarize the demographical, clinical, and laboratorial characteristics of non-recurrence and recurrence groups. Methods: Comprehensive searches were conducted using eight electronic databases. Data regarding the demographic, clinical, and laboratorial characteristics of both recurrence and non-recurrence groups were extracted, and quantitative and qualitative analyses were conducted. Results: Ten studies involving 2071 COVID-19 cases were included in this analysis. The proportion of recurrence cases involving patients with COVID-19 was 17.65% (between 12.38% and 25.16%) while older patients were more likely to experience recurrence (weighted mean difference (WMD)=1.67, range between 0.08 and 3.26). The time from discharge to recurrence was 13.38 d (between 12.08 and 14.69 d). Patients were categorized as having moderate severity (odds ratio (OR)=2.69, range between 1.30 and 5.58), while those with clinical symptoms including cough (OR=5.52, range between 3.18 and 9.60), sputum production (OR=5.10, range between 2.60 and 9.97), headache (OR=3.57, range between 1.36 and 9.35), and dizziness (OR=3.17, range between 1.12 and 8.96) were more likely to be associated with recurrence. Patients presenting with bilateral pulmonary infiltration and decreased leucocyte, platelet, and CD4 + T counts were at risk of

show abstract

Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis

Abstract: Our meta-analysis suggested that periprocedural administration of corticosteroids of catheter ablation was associated with reduction of early but not late recurrence of AF.

Cited by 6 publications

References 31 publications

Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview

Hybrid Ablation of Atrial Fibrillation: A Contemporary Overview

Early arrhythmia recurrence after cryoballoon ablation in atrial fibrillation: A systematic review and meta‐analysis

Factors associated with a SARS-CoV-2 recurrence after hospital discharge among patients with COVID-19: systematic review and meta-analysis

Contact Info

Product

Resources

About